{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:23:26Z","timestamp":1792725806819,"version":"4.5.0"},"reference-count":180,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Controlling the excessive fracture burden in patients with chronic kidney disease (CKD) Stages G4\u2013G5D remains an impressive challenge. The reasons are 2-fold. First, the pathophysiology of bone fragility in patients with CKD G4\u2013G5D is complex and multifaceted, comprising a mixture of age-related (primary male\/postmenopausal), drug-induced and CKD-related bone abnormalities. Second, our current armamentarium of osteoporosis medications has not been developed for, or adequately studied in patients with CKD G4\u2013G5D, partly related to difficulties in diagnosing osteoporosis in this specific setting and fear of complications. Doubts about the optimal diagnostic and therapeutic approach fuel inertia in daily clinical practice. The scope of the present consensus paper is to review and update the assessment and diagnosis of osteoporosis in patients with CKD G4-G5D and to discuss the therapeutic interventions available and the manner in which these can be used to develop management strategies for the prevention of fragility fracture. As such, it aims to stimulate a cohesive approach to the management of osteoporosis in patients with CKD G4\u2013G5D to replace current variations in care and treatment nihilism.<\/jats:p>","DOI":"10.1093\/ndt\/gfaa192","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T15:13:03Z","timestamp":1598627583000},"page":"42-59","source":"Crossref","is-referenced-by-count":206,"title":["European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4\u2013G5D"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-4321","authenticated-orcid":false,"given":"Pieter","family":"Evenepoel","sequence":"first","affiliation":[{"name":"Department of Nephrology, KU Leuven University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Centre for Nephrology, UCL Medical School, Royal Free Campus, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Service of Bone Diseases, Geneva University Hospital, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Haarhaus","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Diaverum Sweden, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Kassim","family":"Javaid","sequence":"additional","affiliation":[{"name":"NDORMS, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Lafage-Proust","sequence":"additional","affiliation":[{"name":"INSERM U1059, CHU, Universit\u00e9 de Lyon, Saint-Etienne, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Prieto-Alhambra","sequence":"additional","affiliation":[{"name":"CSM-NDORMS, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Ure\u00f1a","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Dialysis, AURA Nord Saint Ouen, Saint Ouen, France"},{"name":"Department of Renal Physiology, Necker Hospital, University of Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Cannata-Andia","sequence":"additional","affiliation":[{"name":"Bone and Mineral Research Unit (ISPA) (REDinREN), Hospital Universitario Central Asturias, Oviedo University, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"European Renal Osteodystrophy (EUROD) workgroup, an initiative of the CKD-MBD working group of the ERA-EDTA, and the committee of Scientific Advisors and National Societies of the IOF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vervloet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"D\u2019Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annibal","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syazrah","family":"Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goce","family":"Spasovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,24]]},"reference":[{"key":"2020122916300823800_gfaa192-B1","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease \u2013 a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"2020122916300823800_gfaa192-B2","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"2020122916300823800_gfaa192-B3","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1681\/ASN.2014101017","article-title":"Maintenance dialysis throughout the world in years 1990 and 2010","volume":"26","author":"Thomas","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B4","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B5","first-page":"785","article-title":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"2020122916300823800_gfaa192-B6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"key":"2020122916300823800_gfaa192-B7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0272-6386(96)90461-8","article-title":"Prevalence and risk factors for osteopenia in dialysis patients","volume":"28","author":"Stein","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"2020122916300823800_gfaa192-B8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B9","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/ndt\/gfg403","article-title":"Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients","volume":"18","author":"Urena","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"2020122916300823800_gfaa192-B10","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B11","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00198-018-4592-8","article-title":"Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam","volume":"29","author":"Chen","year":"2018","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00198-003-1435-y","article-title":"Relationship between age, renal function and bone mineral density in the US population","volume":"14","author":"Klawansky","year":"2003","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B13","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1681\/ASN.2007050555","article-title":"The effect of raloxifene treatment in postmenopausal women with CKD","volume":"19","author":"Ishani","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2010121253","article-title":"Differences in bone quality in low- and high-turnover renal osteodystrophy","volume":"23","author":"Malluche","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","article-title":"Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation","volume":"92","author":"Pimentel","year":"2017","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B16","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B17","first-page":"458","article-title":"Bone metabolism, vascular calcifications and mortality: associations beyond mere coincidence","volume":"18","author":"Rodriguez","year":"2005","journal-title":"J Nephrol"},{"key":"2020122916300823800_gfaa192-B18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00198-003-1405-4","article-title":"The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population","volume":"14","author":"Naves","year":"2003","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/M16-2752","article-title":"Benefits and harms of osteoporosis medications in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"166","author":"Wilson","year":"2017","journal-title":"Ann Intern Med"},{"key":"2020122916300823800_gfaa192-B21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nefro.2018.10.009","article-title":"Osteoporosis, bone mineral density and CKD-MBD (II): therapeutic implications","volume":"39","author":"Bover","year":"2019","journal-title":"Nefrologia"},{"key":"2020122916300823800_gfaa192-B22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.nefro.2017.12.006","article-title":"Osteoporosis, bone mineral density and CKD-MBD complex (I): diagnostic considerations","volume":"38","author":"Bover","year":"2018","journal-title":"Nefrologia"},{"key":"2020122916300823800_gfaa192-B23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B25","first-page":"1608","article-title":"Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative\u2013a position paper","volume":"32","author":"Evenepoel","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2020122916300823800_gfaa192-B26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/j.ajkd.2013.12.016","article-title":"Fragility fractures and osteoporosis in CKD: pathophysiology and diagnostic methods","volume":"63","author":"Salam","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2020122916300823800_gfaa192-B27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/kisup.2013.93","article-title":"Uremic osteoporosis","volume":"3","author":"Kazama","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"2020122916300823800_gfaa192-B28","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/ndt\/14.8.1922","article-title":"Risk factors for reduced bone density in haemodialysis patients","volume":"14","author":"Taal","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"2020122916300823800_gfaa192-B29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jbmr.3608","article-title":"Poor vitamin K status is associated with low bone mineral density and increased fracture risk in end-stage renal disease","volume":"34","author":"Evenepoel","year":"2019","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40620-017-0406-x","article-title":"Uremic toxicity and bone in CKD","volume":"30","author":"Yamamoto","year":"2017","journal-title":"J Nephrol"},{"key":"2020122916300823800_gfaa192-B31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2020122916300823800_gfaa192-B32","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.kint.2016.10.008","article-title":"Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation","volume":"91","author":"Evenepoel","year":"2017","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11914-019-00513-1","article-title":"Falls and fractures in diabetes\u2013more than bone fragility","volume":"17","author":"Rasmussen","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"2020122916300823800_gfaa192-B35","doi-asserted-by":"crossref","first-page":"e0196113","DOI":"10.1371\/journal.pone.0196113","article-title":"Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: a systematic review and meta-regression","volume":"13","author":"Mendoza-Pinto","year":"2018","journal-title":"PLoS One"},{"key":"2020122916300823800_gfaa192-B36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.kint.2018.09.018","article-title":"A distinct bone phenotype in ADPKD patients with end-stage renal disease","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B37","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","article-title":"Targeting the Wnt\/\u03b2-catenin pathway to regulate bone formation in the adult skeleton","volume":"148","author":"Baron","year":"2007","journal-title":"Endocrinology"},{"key":"2020122916300823800_gfaa192-B38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","article-title":"Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease","volume":"90","author":"Carrillo-Lopez","year":"2016","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"2020122916300823800_gfaa192-B40","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B41","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000489672","article-title":"Cortical or trabecular bone: what's the difference?","volume":"47","author":"Ott","year":"2018","journal-title":"Am J Nephrol"},{"key":"2020122916300823800_gfaa192-B43","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","author":"Nickolas","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B44","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ndt\/gfy287","article-title":"High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease","volume":"34","author":"Carrillo-Lopez","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2020122916300823800_gfaa192-B45","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1523-1755.2000.00394.x","article-title":"Risk factors for hip fracture among patients with end-stage renal disease","volume":"58","author":"Stehman-Breen","year":"2000","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B46","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.1644","article-title":"Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT)","volume":"27","author":"Jacques","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jbmr.1472","article-title":"Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures","volume":"27","author":"Austin","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2013a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2020122916300823800_gfaa192-B49","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD","volume":"7","author":"Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"Naylor","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B51","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jbmr.2406","article-title":"Bone mineral density predicts fractures in chronic kidney disease","volume":"30","author":"West","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B53","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: US Preventive Services Task Force Recommendation Statement","volume":"319","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"2020122916300823800_gfaa192-B54","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S8756-3282(96)00246-3","article-title":"Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures","volume":"19","author":"Yamaguchi","year":"1996","journal-title":"Bone"},{"key":"2020122916300823800_gfaa192-B56","doi-asserted-by":"crossref","first-page":"e0197965","DOI":"10.1371\/journal.pone.0197965","article-title":"Bone density of the femoral neck in patients on maintenance dialysis","volume":"13","author":"Nakanishi","year":"2018","journal-title":"PLoS One"},{"key":"2020122916300823800_gfaa192-B57","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2215\/CJN.01470209","article-title":"Arteriovenous fistula affects bone mineral density measurements in end-stage renal failure patients","volume":"4","author":"Muxi","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B58","doi-asserted-by":"crossref","first-page":"e0200708","DOI":"10.1371\/journal.pone.0200708","article-title":"The effect of a previous created distal arteriovenous-fistula on radial bone DXA measurements in prevalent renal transplant recipients","volume":"13","author":"Walder","year":"2018","journal-title":"PLoS One"},{"key":"2020122916300823800_gfaa192-B59","doi-asserted-by":"crossref","first-page":"b2266","DOI":"10.1136\/bmj.b2266","article-title":"Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data","volume":"338","author":"Bell","year":"2009","journal-title":"BMJ"},{"key":"2020122916300823800_gfaa192-B60","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1007\/s00198-017-4221-y","article-title":"Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study","volume":"28","author":"Malmgren","year":"2017","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00198-017-4228-4","article-title":"Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors","volume":"29","author":"Malluche","year":"2018","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00223-013-9722-x","article-title":"High prevalence of vertebral fractures assessed by quantitative morphometry in hemodialysis patients, strongly associated with vascular calcifications","volume":"93","author":"Fusaro","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"2020122916300823800_gfaa192-B63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjmed.2015.09.020","article-title":"Vertebral fractures: clinical importance and management","volume":"129","author":"Kendler","year":"2016","journal-title":"Am J Med"},{"key":"2020122916300823800_gfaa192-B64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2215\/CJN.03410708","article-title":"Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients","volume":"4","author":"Toussaint","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B65","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/jbmr.3405","article-title":"Long-term atherosclerotic vascular disease risk and prognosis in elderly women with abdominal aortic calcification on lateral spine images captured during bone density testing: a prospective study","volume":"33","author":"Lewis","year":"2018","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B66","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41574-019-0220-8","article-title":"Fracture prediction, imaging and screening in osteoporosis","volume":"15","author":"Fuggle","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2020122916300823800_gfaa192-B67","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00198-018-4468-y","article-title":"The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease","volume":"29","author":"Aleksova","year":"2018","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B68","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.00720116","article-title":"Trabecular bone score and incident fragility fracture risk in adults with reduced kidney function","volume":"11","author":"Naylor","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B69","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1359\/jbmr.060105","article-title":"Cortical pQCT measures are associated with fractures in dialysis patients","volume":"21","author":"Jamal","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B70","doi-asserted-by":"crossref","first-page":"e0171873","DOI":"10.1371\/journal.pone.0171873","article-title":"Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture","volume":"12","author":"Bielesz","year":"2017","journal-title":"PLoS One"},{"key":"2020122916300823800_gfaa192-B71","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-8587(18)30308-5","article-title":"Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study","volume":"7","author":"Samelson","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2020122916300823800_gfaa192-B72","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.2215\/CJN.09711010","article-title":"Bone microarchitecture in hemodialysis patients assessed by HR-pQCT","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B73","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bone.2012.11.006","article-title":"Clinical risk factors, bone density and fall history in the prediction of incident fracture among men and women","volume":"52","author":"Edwards","year":"2013","journal-title":"Bone"},{"key":"2020122916300823800_gfaa192-B74","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1093\/ndt\/gfr620","article-title":"Tests of neuromuscular function are associated with fractures in patients with chronic kidney disease","volume":"27","author":"West","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2020122916300823800_gfaa192-B75","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.5888\/pcd15.170518","article-title":"Falls and fall-related injuries among US adults aged 65 or older with chronic kidney disease","volume":"15","author":"Kistler","year":"2018","journal-title":"Prev Chronic Dis"},{"key":"2020122916300823800_gfaa192-B76","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00198-018-4406-z","article-title":"The utility of FRAX\u00ae in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study","volume":"29","author":"Przedlacki","year":"2018","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.ajkd.2004.09.027","article-title":"Falls in hemodialysis patients: prospective study of incidence, risk factors, and complications","volume":"45","author":"Desmet","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2020122916300823800_gfaa192-B78","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ckj\/sfu034","article-title":"Falls among hemodialysis patients: potential opportunities for prevention?","volume":"7","author":"Kutner","year":"2014","journal-title":"Clin Kidney J"},{"key":"2020122916300823800_gfaa192-B79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00198-013-2524-1","article-title":"The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease","volume":"25","author":"Jamal","year":"2014","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B80","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.kint.2018.09.022","article-title":"The Fracture Risk Assessment Tool (FRAX\u00aepredicts fracture risk in patients with chronic kidney disease","volume":"95","author":"Whitlock","year":"2018","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B81","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bone.2017.02.008","article-title":"Diagnostic accuracy of FRAX in predicting the 10-year risk of osteoporotic fractures using the USA treatment thresholds: a systematic review and meta-analysis","volume":"99","author":"Jiang","year":"2017","journal-title":"Bone"},{"key":"2020122916300823800_gfaa192-B82","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00198-012-2106-7","article-title":"Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study","volume":"24","author":"Tamaki","year":"2013","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B83","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study","volume":"11","author":"Garnero","year":"2009","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B84","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","article-title":"Use of bone turnover markers in postmenopausal osteoporosis","volume":"5","author":"Eastell","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2020122916300823800_gfaa192-B85","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jbmr.3471","article-title":"Bone turnover markers are not associated with hip fracture risk: a case-control study in the Women's Health Initiative","volume":"33","author":"Crandall","year":"2018","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B86","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","article-title":"A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan","volume":"29","author":"Maruyama","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2020122916300823800_gfaa192-B87","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"2020122916300823800_gfaa192-B88","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2020122916300823800_gfaa192-B89","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: an emerging challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B90","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B91","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00198-016-3868-0","article-title":"Imminent risk of fracture after fracture","volume":"28","author":"Johansson","year":"2017","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B92","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.ajkd.2011.06.006","article-title":"Trial quality in nephrology: how are we measuring up?","volume":"58","author":"Palmer","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2020122916300823800_gfaa192-B93","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S8756-3282(01)00666-4","article-title":"Static histomorphometry of human iliac crest and vertebral trabecular bone: a comparative study","volume":"30","author":"Thomsen","year":"2002","journal-title":"Bone"},{"key":"2020122916300823800_gfaa192-B94","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11914-017-0362-3","article-title":"Biomarkers predicting bone turnover in the setting of CKD","volume":"15","author":"Evenepoel","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"2020122916300823800_gfaa192-B95","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2015.156","article-title":"Sclerostin and DKK1: new players in renal bone and vascular disease","volume":"88","author":"Evenepoel","year":"2015","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B96","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.ki.5002622","article-title":"Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients","volume":"73","author":"Torres","year":"2008","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B97","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10353","article-title":"A microRNA approach to discriminate cortical low boneturnover in renal osteodystrophy","volume":"4","author":"Nickolas","year":"2020","journal-title":"JBMR Plus"},{"key":"2020122916300823800_gfaa192-B98","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1046\/j.1523-1755.2002.00656.x","article-title":"Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosis","volume":"62","author":"Domrongkitchaiporn","year":"2002","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B99","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2215\/CJN.06120809","article-title":"Hyponatremia independent of osteoporosis is associated with fracture occurrence","volume":"5","author":"Kinsella","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00198-015-3233-8","article-title":"Inflammation and the bone-vascular axis in end-stage renal disease","volume":"27","author":"Viaene","year":"2016","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B101","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020122916300823800_gfaa192-B102","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrendo.2017.31","article-title":"Comparative analysis of nutritional guidelines for vitamin D","volume":"13","author":"Bouillon","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"2020122916300823800_gfaa192-B103","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B104","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000338299","article-title":"Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (early-stage) chronic kidney disease","volume":"35","author":"Viaene","year":"2012","journal-title":"Am J Nephrol"},{"key":"2020122916300823800_gfaa192-B106","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1017\/S1368980008002024","article-title":"Low dietary calcium in European postmenopausal osteoporotic women","volume":"12","author":"Bruyere","year":"2009","journal-title":"Public Health Nutr"},{"key":"2020122916300823800_gfaa192-B107","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s00198-017-4230-x","article-title":"Global dietary calcium intake among adults: a systematic review","volume":"28","author":"Balk","year":"2017","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B108","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2215\/CJN.05970809","article-title":"Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content","volume":"5(Suppl 1","author":"Bushinsky","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B109","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ki.2012.33","article-title":"Calcium balance in chronic kidney disease: walking the tightrope","volume":"81","author":"Evenepoel","year":"2012","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B110","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B111","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2215\/CJN.06420909","article-title":"Vitamins K and D status in stages 3-5 chronic kidney disease","volume":"5","author":"Holden","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B112","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/jbmr.1677","article-title":"Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study","volume":"27","author":"Fusaro","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B113","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.berh.2014.07.004","article-title":"Lifestyle modifications to improve musculoskeletal and bone health and reduce disability \u2013 a life-course approach","volume":"28","author":"Jones","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2020122916300823800_gfaa192-B114","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1210\/jc.2017-02163","article-title":"A phase III randomized placebo-controlled trial to evaluate efficacy and safety of romosozumab in men with osteoporosis","volume":"103","author":"Lewiecki","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2020122916300823800_gfaa192-B115","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"2020122916300823800_gfaa192-B116","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41584-019-0172-3","article-title":"Antiresorptive and anabolic agents in the prevention and reversal of bone fragility","volume":"15","author":"Seeman","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2020122916300823800_gfaa192-B117","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bone.2019.07.007","article-title":"Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing","volume":"127","author":"Swallow","year":"2019","journal-title":"Bone"},{"key":"2020122916300823800_gfaa192-B118","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/sdi.12388","article-title":"Pharmacology of bisphosphonates in patients with chronic kidney disease","volume":"28","author":"Ott","year":"2015","journal-title":"Semin Dial"},{"key":"2020122916300823800_gfaa192-B119","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/089686089801800210","article-title":"Pharmacokinetics of clodronate in peritoneal dialysis patients","volume":"18","author":"Saha","year":"1998","journal-title":"Perit Dial Int"},{"key":"2020122916300823800_gfaa192-B120","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/JBMR.050817","article-title":"Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B121","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial","volume":"22","author":"Jamal","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B122","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12882-017-0478-9","article-title":"Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials","volume":"18","author":"Shigematsu","year":"2017","journal-title":"BMC Nephrol"},{"key":"2020122916300823800_gfaa192-B123","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000341864","article-title":"Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study","volume":"36","author":"Mitsopoulos","year":"2012","journal-title":"Am J Nephrol"},{"key":"2020122916300823800_gfaa192-B124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.ajkd.2009.12.039","article-title":"Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial","volume":"56","author":"Toussaint","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"2020122916300823800_gfaa192-B125","first-page":"510","article-title":"Treatment of reduced bone density with ibandronate in dialysis patients","volume":"21","author":"Bergner","year":"2008","journal-title":"J Nephrol"},{"key":"2020122916300823800_gfaa192-B126","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jbmr.3676","article-title":"Effects of denosumab and alendronate on bone health and vascular function in hemodialysis patients: a randomized, controlled trial","volume":"34","author":"Iseri","year":"2019","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B127","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1440-1797.2005.00436.x","article-title":"Effects of short-term alendronate on bone mineral density in haemodialysis patients","volume":"10","author":"Wetmore","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"2020122916300823800_gfaa192-B128","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jbmr.2361","article-title":"Relationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study","volume":"30","author":"Eastell","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11914-017-0361-4","article-title":"What animal models have taught us about the safety and efficacy of bisphosphonates in chronic kidney disease","volume":"15","author":"Allen","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"2020122916300823800_gfaa192-B130","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","article-title":"Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate","volume":"18","author":"Eastell","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B131","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1073\/pnas.1704460114","article-title":"Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance","volume":"114","author":"Lloyd","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020122916300823800_gfaa192-B132","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-014-2929-5","article-title":"Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties","volume":"26","author":"Hassler","year":"2015","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B133","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2215\/CJN.09280915","article-title":"Bone parameters and risk of hip and femur fractures in patients on hemodialysis","volume":"11","author":"Fishbane","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020122916300823800_gfaa192-B134","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00198-004-1662-x","article-title":"Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women","volume":"16","author":"Tank\u00f3","year":"2005","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0272-6386(04)00937-0","article-title":"Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis","volume":"44","author":"Nitta","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2020122916300823800_gfaa192-B136","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jbmr.2058","article-title":"Renal safety in patients treated with bisphosphonates for osteoporosis: a review","volume":"28","author":"Miller","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B137","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/er.2018-00001","article-title":"Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management","volume":"40","author":"Black","year":"2019","journal-title":"Endocr Rev"},{"key":"2020122916300823800_gfaa192-B138","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00198-015-3335-3","article-title":"Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015","volume":"27","author":"Khan","year":"2016","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B139","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00198-019-05002-w","article-title":"Fracture risk following intermission of osteoporosis therapy","volume":"30","author":"Dennison","year":"2019","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1163\/15718093-12341352","article-title":"Vrancken I. Off-label prescription of medication","volume":"22","year":"2015","journal-title":"Eur J Health Law"},{"key":"2020122916300823800_gfaa192-B141","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jbmr.1613","article-title":"A single-dose study of denosumab in patients with various degrees of renal impairment","volume":"27","author":"Block","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B142","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","author":"Jamal","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B143","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00198-018-4533-6","article-title":"Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies","volume":"29","author":"Thongprayoon","year":"2018","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B144","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1210\/jc.2014-1154","article-title":"An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis","volume":"99","author":"Chen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020122916300823800_gfaa192-B145","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/jbmr.2480","article-title":"Sustained modeling-based bone formation during adulthood in cynomolgus monkeys may contribute to continuous BMD gains with denosumab","volume":"30","author":"Ominsky","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B146","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/jc.2017-02669","article-title":"Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis","volume":"103","author":"Dempster","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2020122916300823800_gfaa192-B147","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice-yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: a randomized controlled trial","volume":"16","author":"Bonani","year":"2016","journal-title":"Am J Transplant"},{"key":"2020122916300823800_gfaa192-B148","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2018.01.038","article-title":"Facing cinacalcet-induced hypocalcemia: sit back and relax?","volume":"93","author":"Evenepoel","year":"2018","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B149","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40620-016-0334-1","article-title":"Safety and efficacy of denosumab in osteoporotic hemodialysed patients","volume":"30","author":"Festuccia","year":"2017","journal-title":"J Nephrol"},{"key":"2020122916300823800_gfaa192-B150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM Trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B151","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00198-018-04823-5","article-title":"Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis","volume":"30","author":"Naylor","year":"2019","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B152","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/CIRCULATIONAHA.107.707380","article-title":"Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-\/-)\u00a0mice","volume":"117","author":"Morony","year":"2008","journal-title":"Circulation"},{"key":"2020122916300823800_gfaa192-B153","doi-asserted-by":"crossref","first-page":"e0166792","DOI":"10.1371\/journal.pone.0166792","article-title":"Association of serum osteoprotegerin levels with bone loss in chronic kidney disease: insights from the KNOW-CKD study","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"2020122916300823800_gfaa192-B154","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ndt\/gfv081","article-title":"Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications","volume":"30","author":"Morena","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2020122916300823800_gfaa192-B155","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jbmr.2043","article-title":"RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk","volume":"29","author":"Samelson","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B156","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-020-05391-3","article-title":"Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study","author":"Chen","year":"2020","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B157","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00198-016-3861-7","article-title":"Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia","volume":"28","author":"Ota","year":"2017","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B158","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B159","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.2147\/CIA.S120175","article-title":"Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study","volume":"11","author":"Nishikawa","year":"2016","journal-title":"Clin Interv Aging"},{"key":"2020122916300823800_gfaa192-B160","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00198-015-3377-6","article-title":"Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study","volume":"27","author":"Sumida","year":"2016","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B161","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000316708","article-title":"Treatment of hemodialysis-associated adynamic bone disease with teriparatide (PTH1\u201334): a pilot study","volume":"33","author":"Cejka","year":"2010","journal-title":"Kidney Blood Press Res"},{"key":"2020122916300823800_gfaa192-B162","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.2372","article-title":"Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy","volume":"30","author":"Moe","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B163","doi-asserted-by":"crossref","first-page":"15048","DOI":"10.1073\/pnas.1203085109","article-title":"Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin","volume":"109","author":"Bonnet","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020122916300823800_gfaa192-B164","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"2020122916300823800_gfaa192-B165","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"key":"2020122916300823800_gfaa192-B166","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"2020122916300823800_gfaa192-B167","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","article-title":"Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial","volume":"390","author":"Langdahl","year":"2017","journal-title":"Lancet"},{"key":"2020122916300823800_gfaa192-B168","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.3622","article-title":"One year of romosozumab followed by two years of denosumab maintains fracture risk reductions: results of the FRAME Extension Study","volume":"34","author":"Lewiecki","year":"2019","journal-title":"J Bone Miner Res"},{"key":"2020122916300823800_gfaa192-B169","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jc.2013-1521","article-title":"Sclerostin: another vascular calcification inhibitor?","volume":"98","author":"Claes","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020122916300823800_gfaa192-B170","doi-asserted-by":"crossref","first-page":"e19595","DOI":"10.1371\/journal.pone.0019595","article-title":"The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"2020122916300823800_gfaa192-B171","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1056\/NEJMc1402396","article-title":"Romosozumab in postmenopausal women with osteopenia","volume":"370","author":"Evenepoel","year":"2014","journal-title":"N Engl J Med"},{"key":"2020122916300823800_gfaa192-B172","doi-asserted-by":"crossref","first-page":"e0144119","DOI":"10.1371\/journal.pone.0144119","article-title":"Nonadherence to medication therapy in haemodialysis patients: a systematic review","volume":"10","author":"Ghimire","year":"2015","journal-title":"PLoS One"},{"key":"2020122916300823800_gfaa192-B173","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2006-1526","article-title":"Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis","volume":"92","author":"Delmas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020122916300823800_gfaa192-B174","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"},{"key":"2020122916300823800_gfaa192-B175","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","article-title":"Bone turnover markers: use in osteoporosis","volume":"8","author":"Naylor","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"2020122916300823800_gfaa192-B176","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11657-019-0569-2","article-title":"Imminent fracture risk assessments in the UK FLS setting: implications and challenges","volume":"14","author":"Pinedo-Villanueva","year":"2019","journal-title":"Arch Osteoporos"},{"key":"2020122916300823800_gfaa192-B177","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","article-title":"Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle","volume":"24","author":"Akesson","year":"2013","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B178","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/BOR.0000000000000401","article-title":"Fracture liaison services","volume":"29","author":"Briot","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"2020122916300823800_gfaa192-B179","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00198-004-1675-5","article-title":"Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review","volume":"15","author":"Elliot-Gibson","year":"2004","journal-title":"Osteoporos Int"},{"key":"2020122916300823800_gfaa192-B180","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2215\/CJN.11031017","article-title":"Management of Osteoporosis in CKD","volume":"13","author":"Khairallah","year":"2018","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/36\/1\/42\/35253662\/gfaa192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/36\/1\/42\/35253662\/gfaa192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T16:31:08Z","timestamp":1609259468000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/36\/1\/42\/5938134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,24]]},"references-count":180,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,10,24]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaa192","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,10,24]]}}}